national institute for clinical excellence

Latest articles

News
Health watchdog under fire for refusing use of two bowel cancer drugs on the NHS
Charities condemn NHS cancer drug ruling

Cancer charities have today condemned the decision by the health watchdog not to make two bowel cancer drugs available on the NHS. The National Institute for Clinical Excellence (Nice) decided that bevacizumab (Avastin) and cetuximab (Erbitux), which cost £17,000 and £12,000 per patient respectively, were not cost effective given the other demands on the NHS… Read more »

News
Nice approves use of Herceptin in early stage breast cancer sufferers
Watchdog approves breast cancer drug

Thousands of women will have access to a life-saving new drug on the NHS after the health watchdog today approved Herceptin for use against early stage breast cancer. The decision comes after a long-running battle between patients and primary care trusts (PCT) across the country, to tackle what was described as a “postcode lottery” in… Read more »